Marrone Bio Innovations Posts Wider Quarterly Loss

Marrone Bio Innovations, Inc., a provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, posted a wider third-quarter net loss as expenses rose; however, revenue rose 16% in the period.

The net loss was $8.5 million in the quarter, compared with a loss of $7.2 million a year earlier.

Financial Highlights

  • GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period. GAAP revenues increased 16% to $4.2 million in the third quarter of 2017, compared to $3.6 million in the third quarter of 2016.
  • Product shipments1 grew 36% to $15.2 million for the first nine months of 2017, compared to $11.2 million in the same year-ago period. Product shipments were $3.1 million in the third quarter of 2017, compared to $3.1 million in the third quarter of 2017.
  • Gross margin increased to 41.2% for the first nine months of 2017, compared to 30.6% in the same year-ago period. Gross margin increased significantly to 40.9% in the third quarter of 2017, compared to 31.4% in the third quarter of 2016.
  • In October 2017, the Company entered into an unsecured promissory note with an investor, enabling the funding of certain tranches at the lender’s sole discretion. To date, the Company has received $2.0 million in funding under the note.

“We experienced several noteworthy catalysts in the third quarter of 2017, such as completion of our Grandevo WDG granulation line, as well as receiving EPA registration for MBI-110, which is the seventh product we’ve commercialized in 11 years,” said Dr. Pam Marrone, CEO of MBI. “Despite these major events, unfavorable weather conditions reduced the number of expected sprays in several of our key markets. Historically, the third quarter produces the lowest sales of the year and is the most unpredictable, evidenced by hurricanes Irma and Maria which significantly impacted our sales in Florida and Puerto Rico. Fortunately, our portfolio approach to product development and marketing diversifies our revenue base and reduces the impact of any one variable on the success of the company as a whole, and allowed us to achieve above industry-average growth for the first nine months of 2017.

“We remain positive on the long-term outlook of our business and have made significant progress in penetrating the United States market and abroad. To that end, we have greatly expanded our reach in international markets through select partnerships with regionally significant firms such as ÉLÉPHANT VERT in North Africa, Kenya Biologics in Kenya and Tanzania. We have taken significant steps to increase product awareness in the substantial Central and South American market, such as sponsoring grower education events in Honduras and Chile, as well as successfully advancing field trials in Brazil, which have shown tremendous results to-date.

“We’ve also made an immense amount of progress on the R&D front and are near completing the development of our first generation bio-herbicide, MBI-014, which remains on track for EPA submission in the near-term. MBI-014 will address one of the largest needs of organic farming—controlling weeds—and we believe it will be the first new mode of action herbicide in 25 years. Also in the third quarter, on October 27, 2017, we received EPA registration for MBI-110—which we branded ‘Stargus™’, for specialty crops and ‘Amplitude™’ for row crops. To our knowledge, no other agricultural company has successfully commercialized 7 new agricultural products from 6 active ingredients in such a short amount of time.”

Dr. Marrone concluded: “These R&D advancements, paired with the considerable progress in advancing distribution and product awareness, are translating into greater market opportunities and enhanced potential to create shareholder value.”

Recent Operational Highlights

  • Realized exceptional results from field trials in Brazil for Regalia®, Grandevo®, Majestene®, and Venerate®. MBI now anticipates a clear path to completion of the registration process in the country, paving the way to commercial sales in the large Brazilian crop protection market.
  • Received EPA registration for MBI-110, branded “Stargus™” for specialty crops and “Amplitude™” for row crops. MBI plans to launch Stargus™ in the United States market in 2017.
  • Completed the development of MBI-014 (formerly 010), an organic bio-herbicide that is set for an EPA submission in the near-term.
  • Albaugh, a major row crop seed treatment provider, had a successful first season with the BioST seed treatment containing an MBI microorganism. Preliminary results are positive and point to substantial yield increases over the standards.
  • Developed a strategy and focus to address grower demand of MBI products within the cannabis market through the creation of smaller pack sizes, hiring a cannabis segment sales specialist and utilizing Amazon as a direct-to-consumer sales channel.
  • As part of MBI’s collaboration with Evogene, transgenic plants carrying MBI’s insecticidal genes were developed and one candidate showed promising results (100% kill) against cabbage looper. Additional tests are in progress.
  • Joined a pilot project with AgShift, a Santa Clara-based agriculture technology startup, to assess the impact of the use of biological pesticides on the quality of fresh produce.
  • Signed new distribution agreements in Africa with regionally significant firms such as ÉLÉPHANT VERT in North Africa and Kenya Biologics in Kenya and Tanzania.
  • Finalized a distribution agreement with a large water treatment company for Zequanox.
  • Currently in discussions with several food companies about how to best transition growers to organic and help their grower suppliers with specific pest and disease problems.
  • Sponsored educational symposia for growers in Honduras and Chile with prominent local organizations to spread awareness of modern agricultural production technologies, including the use of biopesticides and stimulants in specialty crops.
  • Completed construction of the Grandevo WDG granulation line at MBI’s Marrone Michigan Manufacturing facility. This is currently producing a second-generation formulation to allow MBI to meet anticipated demand for this innovative new formulation.
  • Discovered new methods to increase the potency of Majestene and Grandevo, driving notably higher gross margins and increasing the effective capacity of the Marrone Michigan Manufacturing facility.
Topics: ,

Leave a Reply



Monsanto, AgriMetis Enter Global Licensing Agreement

The agreement includes an exclusive global license from AgriMetis to Monsanto for agricultural research in row, vegetable, and other crops for a three-year period.


ADAMA’s Nimitz Gets Regulatory Approval in Brazil

Global crop protection company ADAMA announced that it has successfully obtained regulatory approval for its proprietary nematicide, NIMITZ®, in Brazil.


Brazil, China, France to Drive Rapid Biopesticide Growth

The use of biopesticides, primarily live microbial products, as seed treatments increased in almost every country surveyed.


Stockton Rebrands, Changes Name to STK

Stockton, the innovative Israel – based leader in bio-ag technology for sustainable crop protection and aquaculture, has announed a company


Agrolab, BioScience Solutions Form Cooperation Agreement for Biopesticides

Agrolab and BioScience Solutions have announced a cooperation regarding consultancy for development of biopesticides. Harry Teicher, owner and founder of


Biopesticide Regulation: A Comparison of EU and U.S. Approval Processes

Biopesticides (microbial pesticides, bio-derived chemicals, and plant-incorporated protectants) introduce unique and complex modes of action and may be used in


Stockton Group: Chinese Regulation Changes a Boon for Biopesticides

“It’s known that in China when the government decides something it happens fast,” says Guy Elitzur, CEO of Stockton Group, a


Biological Fungicides: A Key Element in Farmers’ Toolboxes

One great challenge of modern agriculture is to find disease control mechanisms that are efficient alternatives to those of chemical


Importance of Giving Biologicals a Head Start

Within past decade or so, the biological crop protection market has expanded at an unprecedented rate. The use of microorganisms

Pam Marrone

Marrone Bio Innovations Forms Distribution Partnership in the Philippines

Marrone Bio Innovations, Inc. (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf


Despite Growth, Old Perceptions Inhibit Adoption of Biopesticides

There are more than 60 companies offering more than 1,400 biopesticide products, creating a powerful wave that will continue to


Marrone Bio Innovations Announces Comprehensive Financing and Debt Restructuring Transaction

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and


BioProtection Association Expands Global Footprint, Elects New President

BioProtection Global (BPG), the global association of regional trade organizations representing the biological products industry, has announced the incorporation of


Slideshow: AgriBusiness Global Hosts Trade Summit Southeast Asia

AgriBusiness Global hosted its Trade Summit Southeast Asia from Dec. 5-6 in Jakarta, Indonesia at the J S Luwansa Hotel.


Marrone Bio Innovations Introduces Amplitude Biofungicide for White Mold Control

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental


Flamingo Commits $2.4 Million Investment to African Biopesticide Subsidiary

Flamingo Horticulture Investments (FHI Ltd), a Sun Capital Europe portfolio organization, has announced it will make a further investment of


Seawin Biotech Group Launches U.S. Business Division

Qingdao Seawin Biotech Group has announced the launch of the U.S. business division. As China’s largest manufacturer of fertilizers made


Valent USA Launches Aveo EZ Nematicide

Aveo EZ is a biological seed protectant that colonizes the roots of the soybean plant to reduce nematode reproduction.


Marrone Bio Innovations Receives EPA Approval for Novel Biofungicide

The product, which is the sixth one to be commercialized by MBI in 11 years, is based on a new strain of Bacillus amyloliquefaciens discovered by MBI.

Latest News


Bayer: Enzymes in Honeybees Determine Neonic Sensitivity

A joint study by Exeter University, Rothamsted Research and Bayer has discovered enzymes in honey bees and bumble bees that determine how sensitive they are to different neonicotinoid insecticides.


China Pesticide Market: Biopesticides, Fungicides Highlight 47 New Products Launched in 2017

In 2017, there were 47 new pesticides registered or launched in China, including 13 fungicides, five insecticides / acaricides /


Nichino America Launches Novel Fungicide

Flutianil, the active ingredient in Gatten, has specific activity against the fungal diseases that cause powdery mildew.

Seeds and Traits

Monsanto Previews Current, Future Pipeline Offerings

Even after the company launched dicamba-tolerant crops to the agricultural marketplace in 2017, Monsanto is gearing up for a busier


Understory Partners with Monsanto in Argentina

Disruptive edge computing weather network deployed in key agriculture regions in Argentina.